Illumina, Inc. announced on 21 September it will buy back cancer screening start-up GRAIL Inc. in a cash and stock deal valued at $8bn, buying out well-known investors such as Amazon’s Jeff Bezos.
Illumina spun out Grail as a separate company four years ago. Grail filed with the